- Home
- AXR
as 01-17-2025 4:00pm EST
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
| Founded: | 1961 | Country: | United States |
| Employees: | N/A | City: | HAVERTOWN |
| Market Cap: | 203.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 34.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.30 | EPS Growth: | -34.73 |
| 52 Week Low/High: | $15.88 - $39.67 | Next Earning Date: | 03-07-2025 |
| Revenue: | $63,223,000 | Revenue Growth: | 54.34% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of AMREP Corporation (AXR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ROBOTTI ROBERT | AXR | Director | Dec 20 '24 | Sell | $31.56 | 13,000 | $410,252.70 | 309,415 | |
| ROBOTTI ROBERT | AXR | Director | Dec 18 '24 | Sell | $31.49 | 18,054 | $564,121.81 | 309,415 |
Latest AMREP Corporation News
AXR Breaking Stock News: Dive into AXR Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 days ago
Owning 44% shares,institutional owners seem interested in AMREP Corporation (NYSE:AXR),
Zacks
16 days ago
The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP
Zacks
17 days ago
Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer
MT Newswires
a month ago
AMREP Insider Sold Shares Worth $564,122, According to a Recent SEC Filing
Zacks
a month ago
AXR Stock Dips After Reporting Q2 Earnings, Revenues Surge Y/Y
Simply Wall St.
a month ago
AMREP Second Quarter 2025 Earnings: EPS: US$0.76 (vs US$0.21 in 2Q 2024)
GlobeNewswire
a month ago
AMREP Reports Second Quarter Fiscal 2025 Results
Zacks
3 months ago
2 Small Caps: Should You Bet the "House"?
Compare AXR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AXR AMREP Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.